文献速递肿瘤 PET/CT放射性药物与辐射防护

整合影像与高胰岛素-正常血糖钳夹评估组织特异性及全身胰岛素敏感性:在2型糖尿病与超重/肥胖人群中的重复性研究

Tissue-specific and whole-body insulin sensitivity by integrated imaging and hyperinsulinemic euglycemic clamp: A repeatability study in people with T2DM and overweight/obesity.
PubMed 文献 · EJNMMI Res · 2025-08-07

本研究在2型糖尿病和超重/肥胖人群中,于标准化条件下进行两次重复检查,采用高胰岛素-正常血糖钳夹联合动态[18F]FDG-PET/MRI评估全身葡萄糖利用率(M值)和组织特异性葡萄糖摄取代谢率(MRGlu),并以组内相关系数(ICC)评价重复性。符合方案集12例中M值ICC为0.95(95%CI 0.86-0.99),骨骼肌MRGlu ICC为0.94,皮下脂肪、内脏脂肪、心肌和脑的重复性为良好至至少中等。结论认为该方法提供的组织特异性胰岛素敏感性定量信息可靠性可与全身葡萄糖利用率评估相当。

要点

  • 符合方案集12例中M值ICC为0.95(95%CI 0.86-0.99),重复性优秀。
  • 骨骼肌MRGlu ICC为0.94,皮下脂肪、内脏脂肪、心肌和脑为良好至至少中等。
  • 全分析集16例重复性较低但至少为中等,强调代谢评估标准化的重要性。

核心结论

  • 动态[18F]FDG-PET/MRI可在高胰岛素-正常血糖钳夹期间提供组织特异性胰岛素敏感性定量信息,其可靠性可与全身葡萄糖利用率评估相当。
  • 该方法有潜力在干预试验中为监测和评估2型糖尿病治疗对葡萄糖摄取和胰岛素抵抗的影响增加价值。

研究设计与样本

  • 研究纳入2型糖尿病和超重/肥胖参与者,在标准化条件下进行两次重复检查。
  • 所有参与者签署知情同意书,研究方案获瑞典伦理审查局批准(#2020-04140)。
  • 过夜禁食后建立高胰岛素-正常血糖钳夹,并进行系列[18F]FDG-PET/MRI扫描。
  • 计算扫描期间全身葡萄糖利用率(M值),并使用Patlak模型计算组织特异性葡萄糖摄取代谢率(MRGlu)。
  • 通过计算组内相关系数(ICC)评估重复性,重复性在符合方案集12例和全分析集16例中评估。

主要发现

  • 符合方案集(PPS)12例中M值ICC为0.95(95%CI 0.86-0.99),表明重复性优秀。
  • 组织特异性MRGlu重复性在骨骼肌为优秀(ICC 0.94),在皮下脂肪、内脏脂肪、心肌和脑为良好至至少中等。
  • 全分析集(FAS n=16)重复性较低但至少为中等,强调代谢评估中标准化的重要性。
  • 测得的M值和组织MRGlu显示出不同程度的胰岛素抵抗。

关键数值与推荐

  • 符合方案集12例中M值ICC为0.95(95%CI 0.86-0.99)。
  • 骨骼肌MRGlu ICC为0.94。
  • 全分析集16例重复性较低但至少为中等。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 全分析集重复性较低但至少为中等,强调标准化的重要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Assessment of glucose uptake by PET imaging under hyperinsulinemic euglycemic clamp (HEC) is an insightful tool for quantification of insulin resistance, a hallmark of diabetes and an area of interest in drug development. To enable the use of the method in metabolic trials, the repeatability of dynamic whole-body PET/MRI assessments of the tissue-specific glucose uptake and the total body glucose utilisation were investigated. The study included participants with type 2 diabetes mellitus (T2DM) and overweight/obesity, for two repeated examinations in standardised conditions. All participants signed informed consent, and the study plan was approved by the Swedish Ethical Review Authority (#2020-04140). After an overnight fast, HEC was established and a series of [18F]FDG-PET/MRI scans were performed. Total body glucose utilisation (M-value) was calculated for the duration of the scan and the tissue-specific metabolic rates of glucose uptake (MRGlu) were calculated using Patlak model. The repeatability was assessed by calculating the intraclass correlation coefficient (ICC). RESULTS: Repeatability was assessed in per protocol set of 12 participants (PPS, defined by a consistent HEC) and in full analysis set (FAS n = 16). The measured M-values and tissue MRGlu demonstrated varying levels of insulin resistance. M-value ICC was 0.95 (95% CI 0.86-0.99) for PPS, indicating excellent repeatability. Tissue-specific MRGlu repeatability was excellent for skeletal muscle (ICC 0.94), and good to at least fair for SAT, VAT, myocardium, and brain. The FAS had lower, but at least fair repeatability, emphasising the importance of standardisation in metabolic assessments. CONCLUSION: Dynamic [18F]FDG-PET/MRI provides quantitative information on tissue-specific insulin sensitivity during hyperinsulinemic euglycemic clamp with a reliability comparable to total body glucose utilisation assessment. The method has potential to add value in monitoring and evaluating T2DM treatment effects on glucose uptake and insulin resistance in interventional trials.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Laitinen I, Litorp H, Sjöberg F, et al. Tissue-specific and whole-body insulin sensitivity by integrated imaging and hyperinsulinemic euglycemic clamp: A repeatability study in people with T2DM and overweight/obesity. EJNMMI Res. 2025. PMID: 40775126. doi:10.1186/s13550-025-01298-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。